Beta Blockers May Hold Key to Unleashing Potential of Checkpoint...

In new research published in the journal Cancer Research, team shows that "beta blocker" drugs appear to be an effective means of reducing beta-2 receptor signaling and, in the process, may...(PRWeb August 30, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14648000.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news